Updates: Company News; Industry trends

Industry trends

More in love with the First Third Party? Mercado returns to Kolenbotai preclinical ADC

Learn more

2023-10-23 17:05:18

10 / 23

2023
Multi pathway optimization strategy for efficient production of 2 '- fucosyllactose by engineered Escherichia coli C41 (DE3)

Learn more

2023-10-23 12:16:04

10 / 23

2023
DeepTech Releases a Research Report on "Frontier Technologies Empowering New Drug Development - Artificial Intelligence | Synthetic Biology | Gene Delivery Technology | Organ and Organ Chips"

Learn more

2023-10-22 16:27:20

10 / 22

2023
Why is the listed company Kaisai Biotechnology located in the 17000 acre Shanxi Synthetic Biology Industrial Park

Learn more

2023-10-19 15:25:11

10 / 19

2023
Synthetic biology is still in its very early stages and is still being explored. "Interview with Liu Chenli from Shenzhen Advanced Institute

Learn more

2023-10-18 15:31:27

10 / 18

2023
Roche pays another 2 billion dollars! Multiple candidate drugs for molecular glue have been obtained and new data shows that they can effectively reduce tumor size

Learn more

2023-10-18 19:17:03

10 / 18

2023
Baiaogu & Enzekangtai | "Challenges and Prospects of Exosome Industrialization" roundtable discussion will be held grandly tomorrow...

Learn more

2023-10-18 17:35:03

10 / 18

2023
Scientists have designed a new method for protein aggregation using disulfide bond reducing agents to break down folded proteins which can be used to generate multifunctional protein coatings

Learn more

2023-10-17 19:14:25

10 / 17

2023

Industry trends

More in love with the First Third Party? Mercado returns to Kolenbotai preclinical ADC

Multi pathway optimization strategy for efficient production of 2 '- fucosyllactose by engineered Escherichia coli C41 (DE3)

DeepTech Releases a Research Report on "Frontier Technologies Empowering New Drug Development - Artificial Intelligence | Synthetic Biology | Gene Delivery Technology | Organ and Organ Chips"

Why is the listed company Kaisai Biotechnology located in the 17000 acre Shanxi Synthetic Biology Industrial Park

Synthetic biology is still in its very early stages and is still being explored. "Interview with Liu Chenli from Shenzhen Advanced Institute

Roche pays another 2 billion dollars! Multiple candidate drugs for molecular glue have been obtained and new data shows that they can effectively reduce tumor size

Baiaogu & Enzekangtai | "Challenges and Prospects of Exosome Industrialization" roundtable discussion will be held grandly tomorrow...

Scientists have designed a new method for protein aggregation using disulfide bond reducing agents to break down folded proteins which can be used to generate multifunctional protein coatings